IDL Biotech AB (XSAT:IDL) FCF Margin % : -12.83% (As of Jun. 2021)

View and export this data going back to 2004. Start your Free Trial

What is IDL Biotech AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. IDL Biotech AB's Free Cash Flow for the three months ended in Jun. 2021 was kr-0.81 Mil. IDL Biotech AB's Revenue for the three months ended in Jun. 2021 was kr6.33 Mil. Therefore, IDL Biotech AB's FCF Margin % for the quarter that ended in Jun. 2021 was -12.83%.

As of today, IDL Biotech AB's current FCF Yield % is -5.65%.

The historical rank and industry rank for IDL Biotech AB's FCF Margin % or its related term are showing as below:

XSAT:IDL' s FCF Margin % Range Over the Past 10 Years
Min: -52.77 Med: 0 Max: 0
Current: -52.77

XSAT:IDL's FCF Margin % is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: -12.715 vs XSAT:IDL: -52.77

IDL Biotech AB FCF Margin % Historical Data

The historical data trend for IDL Biotech AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDL Biotech AB FCF Margin % Chart

IDL Biotech AB Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

FCF Margin %

Get a 7-Day Free Trial

-3.82

-1.62

-12.92

-36.55

-38.54

IDL Biotech AB Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
FCF Margin %	Get a 7-Day Free Trial															-84.26	-108.76	-72.10	-47.49	-12.83

Competitive Comparison of IDL Biotech AB's FCF Margin %

For the Diagnostics & Research subindustry, IDL Biotech AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IDL Biotech AB's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDL Biotech AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where IDL Biotech AB's FCF Margin % falls into.

IDL Biotech AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

IDL Biotech AB's FCF Margin for the fiscal year that ended in Dec. 2020 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2020 )	/	Revenue (A: Dec. 2020 )
	=	-8.381	/	21.748
	=	-38.54 %

IDL Biotech AB's FCF Margin for the quarter that ended in Jun. 2021 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2021 )	/	Revenue (Q: Jun. 2021 )
	=	-0.812	/	6.328
	=	-12.83 %

IDL Biotech AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of IDL Biotech AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

IDL Biotech AB (XSAT:IDL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDL Biotech AB (XSAT:IDL) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Karlsbodavagen 39, Stockholm, SWE

Website

http://www.idl.se

IDL Biotech AB develops, produces and markets In Vitro Diagnostic tests for the health care sector. It offers in vitro diagnostic tests within the clinical areas of oncology and bacteriology. The company's trademark products includes TUBEX, TPS, UBC, MonoTotal and TPAcyk.

IDL Biotech AB (XSAT:IDL) Headlines

No Headlines